ArticleJournal of oral & facial pain and headache2026
Translation, cultural adaptation, and pilot testing of the standardized tool for the assessment of bruxism and the bruxism screener in China.
Article in Journal of oral & facial pain and headache, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundThe newly established Standardized Tool for the Assessment of Bruxism (STAB) and the bruxism screener (BruxScreen) offer thorough, methodical, and readily available instruments for the evaluation and screening of bruxism in clinical settings and research endeavors.
methodsThe Chinese version provided is a translation of the original English text. The Chinese version of the STAB/BruxScreen was developed in accordance with the 12-step guideline for translation and cultural adaptation established by the expert group. The translation team consisted of 13 members: 4 study coordinators, 2 forward translators, 2 rear translators, and 5 expert panelists. Simultaneously, the Chinese iteration of the STAB and BruxScreen underwent pilot testing to assess its comprehensibility and practicality. Pilot testing comprised 60 participants for the STAB (20 patients, 20 dental students, 20 dentists) and 40 independent volunteers for the BruxScreen (20 patients, 10 students, 10 dentists).
resultsThe STAB completion time averaged 17.8 minutes for patients (self-report) and 11.4 minutes and 14.3 minutes for dentists and dental students (examination), respectively. The BruxScreen-Q (questionnaire) completion time averaged 1.6 minutes, and the BruxScreen-C (clinical examination) duration averaged 1.8 minutes per patient. High comprehensibility was achieved, with 95.5% of the STAB items and 100% of the BruxScreen items requiring no clarification. All 20 dentists (100%) endorsed both tools as clinically feasible. The test-retest and inter-examiner reliability of the BruxScreen showed excellent agreement (Kappa > 0.8,
conclusionsThe Chinese versions demonstrate satisfactory preliminary comprehensibility and feasibility; the BruxScreen shows excellent reliability. Comprehensive validation in larger samples is required before these tools can be applied in clinical practice or large-scale screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.